Patients within Niagara Health have been getting opportunities to participate in COVID-19 related clinical trials.
Some of the studies happening at Niagara Health include the REMAP-Cap Study, which is evaluating the clinical effectiveness of various COVID-19 treatments in ICU patients.
There is also the COVI-Prone Study, which is examining whether lying on the stomach for COVID-19 patients with respiratory reduces the need for medical ventilation.
Johan Viljoen, Niagara Health's Chief of Staff spoke of the importance of these trials.
"The opportunity for our patients to be part of these clinical trials is important for discovering new and effective treatments for COVID-19."
Niagara Falls Preps for Ribfest
Hospital Deficits Getting Worse: Report
Man Dies in Lincoln House Fire
Potential Niagara Parks Strike
Man Charged with Possessing Child Porn
Be Wary of Spring Time Scams: NRP
Man Killed Walking Along QEW
Senior Charged with Hate Speech Crime